VMET NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Versamet Royalties Corporation Common Stock · Basic Materials · Other Precious Metals & Mining

Open interactive chart View report data
Latest close 8.83 USD
-2.3% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -19.1% below the Trend Line and sits at 12.4% of its 52-week range. The latest completed week returned -2.3%, after a -25.3% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is expensive relative to peers. The latest news-sentiment score is 51/100. Near-term considerations: volume confirmation is below normal; earnings are due in 24d.

Setup score 32 out of 100
Latest Close 8.83 USD 31 Jul 2026
1W Return -2.3% latest completed week
4W Return -25.3% short-term follow-through
12W Return -27.5% quarterly tape
Trend Breadth 34.7% 17 of 49 weeks active
Volume Ratio 0.9x vs 13-week average
What is working
  • Next-week expectancy is positive at 79.61% based on similar historical setup states.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -2.3% Latest completed week; four-week move -25.3%. Indicator stack 19/0 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 79.61% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 51/100 33 relevant articles in the latest sentiment read. Event risk 24d Next report is scheduled for 26 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -19.1% below the Trend Line and sits at 12.4% of its 52-week range. The latest completed week returned -2.3%, after a -25.3% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.6512-week average 0.74

12-week confirmation

Trend active9/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.65Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -25.3% over four weeks, -27.5% over 12 weeks, and - over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-2.3%
4W-25.3%
12W-27.5%
26W-20.5%
52W-
Active trend streak0 weeks
Active weeks in one year17
Trend breadth34.7%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.95Latest activity-pressure read.
Pressure change-2537.8%Four-week change in activity pressure.
Leadership-Latest relative-leadership reading.
RS change-Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 91% Model confidence 87%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength18/100Blend of value, momentum, and quality. Underlying universe rank 83; rank 1 is best.
Value16/100Relative valuation strength. Underlying universe rank 85; rank 1 is best.
Quality70/100Profitability and accounting quality. Underlying universe rank 31; rank 1 is best.
Momentum36/100Medium-term price momentum. Underlying universe rank 65; rank 1 is best.
Growth89/100Revenue and earnings growth. Underlying universe rank 12; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework26/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
30.6x
Price divided by trailing earnings.
Price / sales
17.8x
Market value relative to trailing revenue.
EV / EBITDA
20.1x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
14.8%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
47.6%
Gross profit retained from each unit of revenue.
Operating margin
74.1%
Operating profit retained from revenue.
Free-cash-flow margin
275.1%
Free cash flow generated from revenue.
Return on invested capital
7.0%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
189.1%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
129.1%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.0%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.8x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment51/100

Weighted news tone is neutral across 33 relevant articles.

3 positive · 29 neutral · 1 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings24dNext report is scheduled for 26 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-86.1%Distance below the 52-week high.
13-week volatility8.3%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+20.4%Week of 10 Apr.
Worst week-18.5%Week of 10 Jul.
Latest week-2.3%Week of 31 Jul.

Shape of recent returns

Strong gains8
Modest gains5
Flat weeks0
Modest losses4
Sharp losses9
Recent vol8.3%13-week weekly-return volatility.
Base vol57.7%52-week weekly-return volatility.
Up/down split27/18Count of positive and negative weeks in the 52-week window.
Average skew22.7% / -7.8%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape36/100

Trend, activity pressure, participation, and risk combine to a 36/100 tape read.

 Indicator analysis44/100

Latest 12-week confirmation: trend 9/12, activity pressure 5/12, relative leadership 0/12.

Activity pressure 0.65; 2 reversal markers Next-Week ExpectancyPositive 79.61%

Next-week expectancy is positive with a 79.61% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors34/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 61; Small Cap Core rank 96 SVQF26/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 538.0 of 726 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment51/100

Weighted news tone is neutral across 33 relevant articles.

VMET|Versamet Royalties Ord Shs|Price:8.610|Chg%:-0.200 Insiders50/100

No recent insider transaction evidence is stored.

 Earnings24d

Next report is scheduled for 26 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20268.83 USD-2.3%10.91 USD9.58 USD-0.95-839.8KOff
24 Jul 20269.04 USD3.2%10.99 USD9.59 USD-0.75-926.0KOff
17 Jul 20268.76 USD-9.0%11.00 USD9.60 USD-0.48-817.3KOff
10 Jul 20269.63 USD-18.5%11.02 USD9.62 USD-0.24-2.0MOn
3 Jul 202611.82 USD-3.1%11.01 USD9.62 USD0.04-691.2KOn
26 Jun 202612.20 USD1.3%10.89 USD9.57 USD0.18-773.8KOn
19 Jun 202612.04 USD-4.0%10.76 USD9.51 USD0.24-670.4KOn
12 Jun 202612.54 USD3.5%10.64 USD9.45 USD0.26-1.3MOn
5 Jun 202612.12 USD-10.4%10.48 USD9.37 USD0.08-1.3MOn
29 May 202613.53 USD13.8%10.31 USD9.31 USD-0.03-807.1KOn
22 May 202611.89 USD6.4%10.15 USD9.20 USD-0.19-706.7KOn
15 May 202611.17 USD-8.3%10.02 USD9.13 USD-0.18-803.2KOn
8 May 202612.18 USD6.7%9.92 USD9.07 USD-0.23-590.9KOn
1 May 202611.42 USD-7.1%9.78 USD8.99 USD-0.21-737.0KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.